SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Topper James N

(Last) (First) (Middle)
601 UNION STREET, SUITE 3200

(Street)
SEATTLE WA 98101

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ANAPTYSBIO INC [ ANAB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2018
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/11/2018 J(1) 1,372,000 D $0 973,612 I See Footnote(1)
Common Stock 05/11/2018 J(2) 301,024 A $0 301,024 I See Footnote(2)
Common Stock 05/11/2018 J(3) 301,024 D $0 0 I See Footnote(3)
Common Stock 05/11/2018 J(4) 31,854 A $0 31,854 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Effective May 11, 2018, Frazier Healthcare V, L.P. ("FH V"), distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by FH V. FHM V, L.L.C. is the general partner of FHM V, L.P. which is the general partner of FH V. The reporting person disclaims beneficial ownership of all shares held by the foregoing entities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
2. Shares acquired by FHM V, L.P. through a distribution in-kind from FH V. FHM V, L.L.C. is the general partner of FHM V, L.P. The reporting person disclaims beneficial ownership of all shares held by the foregoing entities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
3. Effective May 11, 2018, FHM V, L.P. distributed in-kind, without consideration, a total of 301,024 shares of Common Stock of the Issuer to its limited partners.
4. Shares acquired by Dr. Topper through a distribution in-kind from FHM V, L.P.
Remarks:
/s/ Steve R. Bailey, Attorney-In-Fact for James N. Topper 05/15/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
KNOW ALL BY THESE PRESENTS, that each person whose signature appears below hereby 

constitutes and appoints Steve R. Bailey with full power to act singly, his true 

and lawful attorney-in-fact, with full power of substitution, to: (i) sign any 

and all instruments, certificates and documents that may be necessary, desirable 

or appropriate to be executed on behalf of himself as an individual or in his 

capacity as a general partner of any partnership or limited liability company, 

pursuant to Section 13 or 16 of the Securities Exchange Act of 1934, as amended, 

and any and all regulations promulgated thereunder, (ii) file the same (including 

any amendments thereto), with all exhibits thereto, and any other documents in 

connection therewith, with the Securities and Exchange Commission, and any stock 

exchange or similar authority and (iii) take any other action of any type whatsoever

in connection with the foregoing which, in the opinion of such attorney-in-fact, 

may be of benefit to, in the best interest of, or legally required by, the 

undersigned, it being understood that the documents executed by such attorney-

in-fact on behalf of the undersigned pursuant to this power of attorney shall be 

in such form and shall contain
 such terms and conditions as such attorney-in-fact 

may approve in such attorney-in-fact's discretion, granting unto said attorney-

in-fact full power and authority to do and perform each and every act and thing 

necessary, desirable or appropriate. Each of the undersigned hereby grant to the 

attorney-in-fact full power and authority to do and perform any and every act and 

thing whatsoever requisite, necessary or proper to be done in the exercise of any 

of the rights and powers herein granted, as fully to all intents and purposes as 

the undersigned might or could do if personally present with full power of 

substitution or revocation, hereby ratifying and confirming all that such 

attorney-in-fact or such attorney-in-fact's substitute or substitutes, shall 

lawfully do or cause to be done by virtue of this power of attorney and the 

rights and powers herein granted.



This power of attorney shall remain in full force and effect until revoked by 

the undersigned in a signed writing delivered to the attorney-in-fact.



IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 12th day 

of February, 2016.





/s/ Alan Frazier  

Alan Frazier



/s/ Nader Naini  

Nader Naini



/s/ Patrick Heron  

Patrick Heron



/s/ James Topper  

James Topper



/s/ Nathan Every  

Nathan Every